Indiana University

PARP Inhibitors to Treat Breast Cancer

views 3684
Air date: October 18, 2009

Host: Kathy Miller, MD

Cancer Men's & Women's Health Research
Email Email
Share Sound Medicine Share this segment
MP3 download Download MP3

Interview: James Ford, MD,
Associate professor of medicine, genetics and pediatrics
Stanford University School of Medicine



We pick up today where we left off last week, with more news about one of the most encouraging threads of research into the causes and treatments for breast cancer.

It’s an enzyme that’s in all of our cells, called PARP, which stands for: Poly-a-d-p-ribose polymerase. You can see why it’s called PARP.

One doctor who has been studying PARP is James Ford.
He’s on the faculty at Stanford University School of Medicine and is the co-author of a new study that has the breast cancer research community buzzing.

Comments

No comments yet
Add a comment